FDA Alert
FDA Alert
08/24/2023

Anthony Calabro, MA

Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
FDA Alert
FDA Alert
07/24/2023

Jessica Ganga

Jessica Ganga
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
07/24/2023
FDA alert
FDA alert
05/04/2023

Jessica Ganga

Jessica Ganga
After an ongoing study, the FDA approves the first vaccine for the highly contagious respiratory virus for us in the United States.
05/04/2023